A Huntsville company with less tMoreadith_Serinahan ten employees may have a new drug that could change the way Parkinson’s disease patients receive medications. HudsonAlpha associate company Serina Therapeutics has begun a clinical trial for SER-214. This drug was developed using the company’s patented polymer technology. CEO Randall Moreadith, M.D., Ph.D. explains in a segment from WAAY TV.

Navigation

Color Skin